Buy One Get One free -Llimited Time Offer X
Mimcipar, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Hyperparathyroidism. Mimcipar also has some secondary and off-label uses. These are listed below.
The right dosage of Mimcipar depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Mimcipar as well, which are listed below. Normally, these side effects of Mimcipar are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Mimcipar is Unknown for pregnant women and Unknown for women who are breastfeeding. Further, the section on Mimcipar related warnings talks about Mimcipar's effects on the liver, heart and kidney.
Some other conditions that can be affected by Mimcipar are listed in the contraindications section below.
Additionally, Mimcipar may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Mimcipar is considered safe while driving, and is addictive.
Mimcipar is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Mimcipar is used -
Moderate
Mild
Unknown
Is the use of Mimcipar safe for pregnant women?
No research has not been done till date on the safety of Mimcipar for pregnant women. So its effects on pregnant women are unknown.
Is the use of Mimcipar safe during breastfeeding?
There is no research available on the side effects of Mimcipar in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Mimcipar on the Kidneys?
Mimcipar may have mild side effects on the kidneys.
What is the effect of Mimcipar on the Liver?
Mimcipar can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Mimcipar on the Heart?
You may experience side effects on your heart after taking Mimcipar. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Mimcipar should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Mimcipar unless your doctor advises you to do so -
Is this Mimcipar habit forming or addictive?
No, you will not get addicted to Mimcipar.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Mimcipar since it does not cause drowsiness.
Is it safe?
Mimcipar is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Mimcipar cannot treat any kind of mental disorder.
Interaction between Food and Mimcipar
Mimcipar may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Mimcipar
It is difficult to say anything about the effect of Mimcipar and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sensipar® (cinacalcet)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 338-339
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 320-321